| Q48648882 | 1 -O-alkyl-2-(omega-oxo)acyl-sn-glycerols from shark oil and human milk fat are potential precursors of PAF mimics and GHB. |
| Q34982833 | A new approach to control the enigmatic activity of aldose reductase. |
| Q28382891 | A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases |
| Q34895688 | ALDOSE REDUCTASE: New Insights for an Old Enzyme |
| Q26852122 | Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons |
| Q36716474 | Aldehyde metabolism in the cardiovascular system. |
| Q42004611 | Aldehyde reductase activity in the antennae of Helicoverpa armigera |
| Q36370381 | Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health |
| Q36579665 | Aldo-keto reductase 1 family B7 is the gene induced in response to oxidative stress in the livers of Long-Evans Cinnamon rats. |
| Q34028973 | Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway |
| Q44654610 | Aldose Reductase Catalyzes Reduction of the Lipid Peroxidation Product 4-Oxonon-2-enal |
| Q36204013 | Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury |
| Q37751655 | Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. |
| Q35227388 | Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts |
| Q35600403 | Aldose reductase deficiency in mice protects from ragweed pollen extract (RWE)-induced allergic asthma |
| Q84763738 | Aldose reductase is a potent regulator of TGF-β1 induced expression of fibronectin in human mesangial cells |
| Q40234862 | Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages |
| Q44326992 | Aldose reductase mediates the mitogenic signals of cytokines |
| Q38381878 | Aldose reductase participates in the downregulation of T cell functions due to suppressor macrophages |
| Q36543639 | Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice |
| Q44976583 | Aldose reductase regulates TNF-alpha-induced cell signaling and apoptosis in vascular endothelial cells |
| Q44724775 | Aldose reductase regulates TNF-α-induced inducible nitric oxide synthase expression in human mesangial cells |
| Q36330024 | Aldose reductase-catalyzed reduction of aldehyde phospholipids |
| Q37455375 | Aldose reductase: a novel therapeutic target for inflammatory pathologies. |
| Q28387404 | Arsenic and cardiovascular disease |
| Q41969694 | Binding energy and specificity in the catalytic mechanism of yeast aldose reductases |
| Q38302714 | Binding of pyridine nucleotide coenzymes to the beta-subunit of the voltage-sensitive K+ channel |
| Q29248463 | Biological Chemistry and Functionality of Protein Sulfenic Acids and Related Thiol Modifications |
| Q93196837 | Carnosine protects cardiac myocytes against lipid peroxidation products |
| Q43577663 | Characterization of the glutathione binding site of aldose reductase |
| Q35130660 | Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors |
| Q52720976 | Deficiency of aldose reductase exacerbates early pressure overload-induced cardiac dysfunction and autophagy in mice. |
| Q35565861 | Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications |
| Q37164094 | Detoxification reactions: relevance to aging |
| Q38148786 | Development of aldose reductase inhibitors for the treatment of inflammatory disorders |
| Q28205423 | Expression and activities of aldo-keto oxidoreductases in Alzheimer disease |
| Q36499780 | Glutathione level regulates HNE-induced genotoxicity in human erythroleukemia cells |
| Q35011881 | Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds |
| Q28360926 | Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells |
| Q40010526 | Inhibition of aldose reductase attenuates endotoxin signals in human non-pigmented ciliary epithelial cells |
| Q37142547 | Interaction of aldehydes derived from lipid peroxidation and membrane proteins |
| Q90625036 | Intra-site differential inhibition of multi-specific enzymes |
| Q73675950 | Kinetic and structural characterization of the glutathione-binding site of aldose reductase |
| Q44185495 | Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase |
| Q39107278 | Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells |
| Q36538348 | Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3. |
| Q33301880 | Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure |
| Q73082164 | Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase |
| Q28564219 | Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth |
| Q38096444 | Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. |
| Q54371888 | Overproduction of a rice aldo-keto reductase increases oxidative and heat stress tolerance by malondialdehyde and methylglyoxal detoxification. |
| Q35554080 | Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls |
| Q34074329 | Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids |
| Q39071113 | Protein alkylation by the α,β-unsaturated aldehyde acrolein. A reversible mechanism of electrophile signaling? |
| Q37061605 | Protein functional surfaces: global shape matching and local spatial alignments of ligand binding sites |
| Q44277947 | Protein kinase C-dependent phosphorylation and mitochondrial translocation of aldose reductase |
| Q28749528 | Protein modification by acrolein: formation and stability of cysteine adducts |
| Q37909259 | Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents. |
| Q28564820 | Redox activation of aldose reductase in the ischemic heart |
| Q37400729 | Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue |
| Q38163001 | Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease |
| Q43577685 | Regulation of vascular smooth muscle cell growth by aldose reductase |
| Q37809549 | Role of 4-hydroxy-trans-2-nonenal in cell functions |
| Q40603642 | Role of aldose reductase in TNF-alpha-induced apoptosis of vascular endothelial cells |
| Q37201268 | Role of aldose reductase in the metabolism and detoxification of carnosine-acrolein conjugates |
| Q39260228 | Role of nitric oxide in regulating aldose reductase activation in the ischemic heart |
| Q43577677 | Structural and functional properties of aldose xylose reductase from the D-xylose-metabolizing yeast Candida tenuis |
| Q28345215 | Structural and kinetic modifications of aldose reductase by S-nitrosothiols |
| Q42529346 | Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes |
| Q42651690 | Synthesis, quantification, characterization, and signaling properties of glutathionyl conjugates of enals |
| Q38256368 | The "Goldilocks Zone" from a redox perspective-Adaptive vs. deleterious responses to oxidative stress in striated muscle |
| Q56760512 | The aldo-keto reductase superfamily and its role in drug metabolism and detoxification |
| Q92884406 | The combination of loss of glyoxalase1 and obesity results in hyperglycemia |
| Q37774015 | Understanding the role of aldose reductase in ocular inflammation |